Mars completes acquisition of Cerba HealthCare Group’s stake in French veterinary diagnostics businesses Cerba Vet and ANTAGENE
July 02 2024 - 10:30AM
Business Wire
Investment in Cerba Vet and ANTAGENE to broaden
and enhance access to diagnostics solutions in France and better
serve more veterinary professionals and pets
Mars, Incorporated (“Mars”) today announced that it has
completed its previously announced acquisition of Cerba
HealthCare’s ownership stake in Cerba Vet and ANTAGENE. Cerba Vet
and ANTAGENE now complement the diagnostics portfolio in Mars
Petcare’s Science & Diagnostics division.
Nefertiti Greene, President, Mars Science &
Diagnostics, said: “We are excited to join forces with the
teams from Cerba Vet and ANTAGENE. Cerba Vet and ANTAGENE
complement Mars Science & Diagnostics, which includes a global
veterinary diagnostics business, Antech, and leading cat and dog
genetic testing business, Wisdom Panel. Together we will further
the Mars Petcare Purpose: A BETTER WORLD FOR PETS.”
ABOUT MARS, INCORPORATED
Mars, Incorporated is driven by the belief that the world we
want tomorrow starts with how we do business today. As a $50bn
family-owned business, our diverse and expanding portfolio of
leading pet care products and veterinary services support pets all
around the world and our quality snacking and food products delight
millions of people every day. We produce some of the world’s
best-loved brands including ROYAL CANIN®, PEDIGREE®, WHISKAS®,
CESAR®, DOVE®, EXTRA®, M&M’s®, SNICKERS® and BEN’S ORIGINAL™.
Our international networks of pet hospitals, including BANFIELD™,
BLUEPEARL™, VCA™ and ANICURA™ span preventive, general, specialty,
and emergency veterinary care, and our global veterinary
diagnostics business ANTECH® offers breakthrough capabilities in
pet diagnostics. The Mars Five Principles – Quality,
Responsibility, Mutuality, Efficiency and Freedom – inspire our
150,000 Associates to act every day to help create a better world
for people, pets and the planet.
For more information about Mars, please visit www.mars.com. Join
us on Facebook, Instagram, LinkedIn and YouTube.
About Mars Science & Diagnostics
Mars Science & Diagnostics is a division of Mars Petcare, a
diverse business dedicated to one purpose: A BETTER WORLD FOR
PETS™. Science & Diagnostics brings together the power of
leading pet health science with expertise across diagnostics, data,
and technology to improve outcomes in pet health. Our veterinary
diagnostics business Antech spans in-house diagnostic laboratory
instruments and consumables, including rapid assay diagnostic
products and digital cytology services; local and cloud-based data
services; practice information management software and related
software and support; reference laboratories around the globe;
veterinary imaging and technology; education; and board-certified
specialist support services. Our at-home diagnostics offering
includes Wisdom Panel, the world’s most accurate pet DNA test. For
60 years, our Waltham Petcare Science Institute has been advancing
science to better understand pet health.
About Cerba HealthCare
Cerba HealthCare, a leading global player in medical
diagnostics, aims to support the evolution of health systems
towards more prevention. It draws on more than 50 years of
expertise in clinical pathology to better assess the risk of
diseases development, detect and diagnose diseases earlier, and
optimize the effectiveness of personalized medicine.
Every day, on five continents, the Group's 15,000 employees
sustain the transformation of medicine, driven by one deep
conviction: to advance diagnosis is to advance health.
Cerba HealthCare, enlightening health.
Additional information is available at
www.cerbahealthcare.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240702027806/en/
Mars, Incorporated media inquiries: Kekst CNC James Lindsay
James.lindsay@kekstcnc.com